Transcriptional Regulation of the Mouse Interleukin-2 Receptor Beta Chain Gene by Ets and Egr-1
Overview
Authors
Affiliations
To clarify the mechanisms and factors involved in the regulation of mouse IL-2Rbeta gene expression, we isolated the 5'-flanking region of IL-2Rbeta gene and investigated the promoter activity. Here we elucidated the positive regulatory regions, the most potent of which are located between -50 to -30bp and -164 to -135bp. These regions contain a potentially functional Ets and Egr-1-binding sites whose mutations abrogate promoter activity. Data from electrophoretic mobility shift assay indicate that Ets and Egr-1, but not Sp1, bind to the positive regulatory regions, -50 to -30bp and -164 to -135bp, respectively. Furthermore, recruitment of Ets and Egr-1 at endogenous IL-2Rbeta promoter segments in an IL-2-dependent F7 cells was verified by the chromatin immunoprecipitation assay. This study for the first time delineates the molecular mechanisms underlying regulation of mouse IL-2Rbeta gene transcription by Ets family proteins, partially with Egr-1, and thereby further elucidates the molecular basis of lymphocyte activation and differentiation.
NFAT1 and NFκB regulates expression of the common γ-chain cytokine receptor in activated T cells.
Shim J, Lee S, Jeong J, Kim H, Son W, Park J Cell Commun Signal. 2023; 21(1):309.
PMID: 37904191 PMC: 10617197. DOI: 10.1186/s12964-023-01326-7.
IFNs Drive Development of Novel IL-15-Responsive Macrophages.
Gordon S, Nishiguchi M, Chase J, Mani S, Mainigi M, Behrens E J Immunol. 2020; 205(4):1113-1124.
PMID: 32690654 PMC: 7415599. DOI: 10.4049/jimmunol.2000184.
Gupta R, Yan X, Barrientos J, Kolitz J, Allen S, Rai K J Immunol. 2018; 201(5):1570-1585.
PMID: 30068596 PMC: 6103916. DOI: 10.4049/jimmunol.1800591.
Molecular mechanisms influencing NK cell development: implications for NK cell malignancies.
Mujaj S, Spanevello M, Gandhi M, Nourse J Am J Blood Res. 2012; 1(1):34-45.
PMID: 22432064 PMC: 3301417.
Extrinsic and intrinsic regulation of early natural killer cell development.
Boos M, Ramirez K, Kee B Immunol Res. 2008; 40(3):193-207.
PMID: 18266115 DOI: 10.1007/s12026-007-8006-9.